News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website


Brain Tumor Awareness Month 2019 Webinar Series! 2 webinars in the next few days!


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 We have one this Sunday and Wednesday!  Both have excellent speakers.  Sunday is on Immunotherapies, Wednesday is on Onc-201 for DIPG and H3K27M mutant gliomas.


Posted on: 05/09/2019

Brain Tumor Awareness Month 2019 Webinar Series!        

 This is a good opportunity to meet the experts and ask questions! 

  • 5/12/2019: SUNDAY 7pm Eastern Time.
    Manmeet Ahluwalia, MD, FACP
    Associate Director and Head of Operations, Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic.
    Professor, Cleveland Clinic Lerner College of Medicine
    Topic: Immunotherapy of brain tumors with an emphasis on: The SurVaxM Vaccine, Checkpoint Inhibitors and Toca 511 
     
  • 5/15/2019: WEDNESDAY 7pm Eastern Time.
    Speaker: Wolfgana Oster, MD PhD
    CEO, Oncoceutics
    Topic: Onc-201 for DIPG and H3K27M mutant gliomas! 
     
  • 5/19/2019: SUNDAY 7pm Eastern Time
    Harry Gruber, MD 
    President, Tocagen
    Topic: Toca 511 
     
  • 5/26/19: SUNDAY 7pm Eastern Time
    Joseph Zabramski, MD 
    Emeritus Professor, Neurosurgery, Barrow Neurological Institute
    Topic: Gamma Tiles 
     
  • Go to virtualtrials.com/webinar for details and to participate!

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740